ReviewJournal of Alzheimer's disease reports
Artificial intelligence algorithms for the prediction of cognitive decline and dementia: A theoretical-historical narrative review.
Review in Journal of Alzheimer's disease reports. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Population aging has increased the prevalence of neurodegenerative disorders associated with dementia, with Alzheimer's disease remaining the leading cause worldwide. Early identification of individuals at risk of cognitive decline, particularly those with mild cognitive impairment, remains a major clinical and scientific challenge. In this context, artificial intelligence has emerged as a promising framework for prognostic modeling and for the identification of clinically relevant predictors of disease onset and progression. This narrative review provides a theoretical and historical synthesis of the main machine learning and deep learning approaches used to predict cognitive decline and dementia from multimodal data, including biomarkers, clinical and demographic variables, cognitive measures, and neuroimaging markers. The review examines the methodological evolution of the field, from traditional statistical approaches to ensemble methods and deep neural architectures, and discusses the growing role of multimodal and longitudinal data integration. It also highlights major unresolved issues, including limited external validation, reduced interpretability, restricted generalizability, and the gap between predictive performance and clinical implementation. Overall, artificial intelligence has substantially advanced prediction research in cognitive decline and dementia, but its routine clinical adoption will depend on more rigorous validation, improved transparency, and stronger integration between neuroscience, clinical practice, and data science.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.